Journal for ImmunoTherapy of Cancer (@jitcancer) 's Twitter Profile
Journal for ImmunoTherapy of Cancer

@jitcancer

The official journal of @SITCancer, covering all aspects of tumor immunology and cancer immunotherapy. #JITC Editor-in-Chief: Michael T. Lotze, MD

ID: 1150769339466952705

linkhttps://jitc.bmj.com/ calendar_today15-07-2019 14:09:25

5,5K Tweet

8,8K Followers

1,1K Following

Journal for ImmunoTherapy of Cancer (@jitcancer) 's Twitter Profile Photo
Journal for ImmunoTherapy of Cancer
@jitcancer

7 months ago

CD20 monoclonal antibody & calcineurin inhibitors were linked to higher COVID-19 breakthrough infection rates. The authors argue this observation calls for tailored patient counseling and infection prevention strategies for patients treated with these medications. 6/9

CD20 monoclonal antibody & calcineurin inhibitors were linked to higher COVID-19 breakthrough infection rates. The authors argue this observation calls for tailored patient counseling and infection prevention strategies for patients treated with these medications. 6/9